HCPCS code J3401 — Vyjuvek 5x10^9pfu/ml, 0.1 ml.
Status: Active.
Effective Jan 1, 2024.
Source: CMS HCPCS Level II.
J3401
ActiveVyjuvek 5x10^9pfu/ml, 0.1 ml
Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2024
Code type:
alphanumeric
OPPS Status:
G
— Pass-through drugs and biologicals
OPPS APC:
0716
MUE — Medically Unlikely Edits
Maximum units of J3401 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| Outpatient Hospital | 25 |
| Practitioner Services | 25 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 82194-0510-02 | Vyjuvek |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q1Vyjuvek 5x10^9pfu/ml, 0.1 ml